Acarix
Kongens Lyngby
About Acarix
Acarix A/S is based on pioneering research performed at the Aalborg University, Denmark, initiated in 2004. The research group received the award, ‘MedicoPrisen’, from Medicoindustrien (Danish Medtech trade association) in 2007. A research and development collaboration was established in 2007 between Aalborg University and Coloplast A/S, receiving public support from the Danish National Advanced Technology Foundation in 2008. Acarix A/S was established in 2009 as a spin-out company from Coloplast A/S with Coloplast A/S and Aalborg University as the major shareholders. In 2010 Acarix A/S succeeded attracting venture capital from Seed Capital (DK), Sunstone Capital (DK) and Seventure Partners (F). In 2011 Acarix A/S and collaborators furthermore achieved funding of 5.3 million DKK from the Danish Business Innovation Fund.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $10.7M
- Funding stage: IPO
- Last round: Series Unknown (Nov 2016)
- Ticker: fra:7AC
- Website: acarix.com
- Phone: +45 49 11 14 81
Industries & Categories
Biotechnology, Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/acarix-132147 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.